Glycodin is a cough syrup launched in 1930 by Alembic Pharmaceuticals. It was switched from prescription to over-the-counter in 2002. While it was a Rs. 10 crore brand in 2000, it now faces competition from other cough syrups. The product formulation was changed in 2015 when codeine was replaced. It is marketed for cough, cold, and respiratory infections, and sold for Rs. 60 for 50 ml and Rs. 91.60 for 100ml primarily through chemists and doctors with some advertisement and promotion. Lack of consumer awareness and promotional activities are identified as key issues.
2. Introduction
Brand name Glycodin
Company Alembic Pharmaceuticals
Launched in 1930
Switched from Rx to OTC- 2002
Turnover Rs. 10 Crore (2002)
3. History
Rs. 10 Cr brand in 2000
Facing major competition from
Phensydryl, Benadryl, Corex, DCold,
Ascoril
Banned FDCs in 2015
Relaunched the product by replacing
codeine with dextromethorphan,
terpene hydrate, menthol, syrup
glycerin base.
Tablet- paracetamol,
phenylpropanolamine, caffeine
24. Marketing Mix
Product
Cough and cold, Respiratory tract
infections, expectorants, throat irritation
Price
50 ml for Rs. 60
100ml for Rs. 91.60
25. Place
Chemists and Doctors
Promotion
Advertisement
12+1= 13
https://www.youtube.com/watch?v=md-
wY2yoF9Q
26. Key Learnings
Lack of Consumer awareness
Absence of promotional inputs at the
retailers
Lack of promotion through TV
commercials
Excessive dependency on doctors and
chemists
27. Suggestions
High visibility- Advertisements,
Promotional Inputs
Increase awareness- medical camps,
Upcoming hospitals in micro interiors
Promotions through commercial
advertisements like TV Ads
Social Tie-ups- Nursing Homes, NGOs
Promotional Stickers at chemist
outlets
28. Secure shelf space for your product
Monitor and preserve brand equity
Free samples at crowded places like
annual fairs